Imo yesilumkiso sekhampasi iluhlaza: Kwimeko yamva nje yesilumkiso kwikhampasi ye-UMMS, iindaba kunye nezixhobo, nceda undwendwele umassmed.edu/coronavirus
Njengenxalenye yenkqubo yeNational Institute of Health's Rapid Diagnostic Acceleration (RADx), uphononongo olude olubhalwe ngabaphandi abavela kwiYunivesithi yaseMassachusetts Medical School yachaza ukuba uvavanyo lwePCR kunye novavanyo olukhawulezayo lwe-antigen ye-SARS-CoV-2 luluncedo ekubhaqweni. usulelo Isebenza ngokulinganayo.Nika ubuncinci kabini ngeveki.
Ngokutsho kwe-NIH press release, nangona uvavanyo lwe-PCR lobuqu luthathwa njengomgangatho wegolide, lunovakalelo ngakumbi kunovavanyo lwe-antigen, ngakumbi kumanqanaba okuqala okusuleleka, kodwa iziphumo zibonisa ukuba xa kwenziwa rhoqo njengenxalenye yenkqubo yokuhlola, ezi zimbini zimbini. iindlela zokuvavanya zinovakalelo ngakumbi.Uvakalelo lunokufikelela kuma-98%.Ezi ziindaba ezilungileyo kwiinkqubo ezibanzi zokuthintela, kuba uvavanyo lwe-antigen kwinqanaba lokunyamekela okanye ekhaya linokubonelela ngeziphumo ezikhawulezayo ngaphandle komyalelo kwaye kubiza ngaphantsi kovavanyo lwebhubhoratri.
Uphando lupapashwe kwi "Journal of Infectious Diseases" ngoJuni 30. Abaphandi abavela kwiYunivesithi yase-Illinois e-Urbana-Champaign, i-Johns Hopkins School of Medicine, kunye ne-National Institute of Biomedical Imaging and Bioengineering ababhala eli phepha: of Medicine Laura L. ·Gibson (Laura L. Gibson);U-Alyssa N. Owens, Ph.D., uMququzeleli woPhando;UJohn P. Broach, MD, MBA, MBA, uNjingalwazi oNcedisayo we-Emergency Medicine;UBruce A. Barton, i-PhD, i-Population kunye noNjingalwazi we-Quantitative Health Sciences;UPeter Lazar, umphuhlisi wedatha yesicelo;kunye noDavid D. McManus, MD, uRichard M. Haidack uNjingalwazi wezoNyango, uSihlalo weMedicine kunye noNjingalwazi.
UGqr. Bruce Tromberg, uMlawuli we-NIBIB, isebe le-NIH, uthe: “Ukwenza uvavanyo olukhawulezayo lwe-antigen ekhaya kabini ukuya kathathu ngeveki yindlela enamandla nefanelekileyo yokuba abantu bavavanye usulelo lwe-COVID-19.“Ngokuvulwa kwezikolo kunye namashishini, umngcipheko wosulelo lomntu unokutshintsha yonke imihla.Uvavanyo oluqhubekayo lwe-antigen lunokunceda abantu balawule lo mngcipheko kwaye benze ngokukhawuleza ukuthintela ukusasazeka kwale ntsholongwane. ”
Abaphandi baqokelele iindlela ezimbini zeempumlo ze-swabs kunye neesampulu zamathe kubasebenzi abathatha inxaxheba kunye nabafundi ngexesha lenkqubo yokuhlola i-COVID-19 kwiYunivesithi yase-Illinois e-Urbana-Champaign iintsuku ezili-14 ezilandelelanayo.Enye yeempumlo zomthathi-nxaxheba ngamnye yathunyelwa kwilabhoratri yeYunivesithi yaseJohns Hopkins ukujonga ukukhula kwentsholongwane ephilayo kwinkcubeko kunye nokulinganisa ixesha apho isifundo sinokuludlulisela kwabanye usulelo.
Abaphandi ke bathelekisa iindlela ezintathu zokufumanisa i-COVID-19: uvavanyo lwePCR yamathe, uvavanyo lwe-PCR yeempumlo, kunye novavanyo olukhawulezayo lwe-antigen yeempumlo.Babala ubuntununtunu bendlela nganye yovavanyo lokubona i-SARS-CoV-2 kwaye balinganise ubukho bentsholongwane ephilayo kwiiveki ezimbini zosulelo.
Xa abaphandi babala uvakalelo lovavanyo olusekwe kwisigqi sovavanyo rhoqo ngeentsuku ezintathu, baxela ukuba nokuba basebenzise uvavanyo lwe-antigen olukhawulezayo okanye uvavanyo lwe-PCR, uvakalelo lokufumanisa usulelo lwaluphezulu kune-98%.Xa bevavanya kuphela ubuninzi bokufunyanwa kanye ngeveki, uvakalelo lwe-PCR lokubona impumlo kunye namathe lwalusephezulu, malunga ne-98%, kodwa uvakalelo lokufunyanwa kwe-antigen kwehla ukuya kwi-80%.
"Umceli mngeni ekutolikeni iziphumo zovavanyo lwe-PCR okanye i-antigen kukuba uvavanyo oluqinisekileyo lunokuthi lubonise ubukho bosulelo olusulelayo (inkcazo ephantsi) okanye lungayifumani intsholongwane ephilayo kwisampulu (uvakalelo oluphantsi), ngokulandelanayo," utshilo u-co-leader Dr. Gibson.Undoqo wophando lwezonyango lwe-RADx Tech.
“Ukwahluka kolu phando kukuba sidibanisa i-PCR kunye nokufunyanwa kwe-antigen kunye nenkcubeko yentsholongwane njengophawu olosulelayo.Olu yilo lophando lutyhila eyona ndlela ilungileyo yokusebenzisa uhlobo ngalunye lovavanyo, kwaye lunciphisa umngcipheko wokurhanelwa ukuba yi-COVID-19 Isigulana sichaza ifuthe lomceli mngeni weziphumo zabo. ”
UGqr. Nathaniel Hafer, uprofesa oncedisayo weyeza leemolekyuli kunye nomphandi oyintloko weRADx Tech Study Logistics Core, wathi: "Njengomzekelo wempembelelo yomsebenzi wethu, idatha esiyiqokelelayo inceda ukunika iCDC ulwazi malunga nabantu abahlukeneyo."
UDkt. Hafer wabhekisela kwindima ephambili ye-UMass School of Medicine kuyilo, ukuphunyezwa kunye nokuhlalutya kolu vavanyo lovakalelo.Wancoma kakhulu iqela lophando leYunivesithi yaseMassachusetts Medical School-ekhokelwa nguGqr Broach, kuquka nomlawuli weprojekthi uGul Nowshad kunye nomqhubi wophando uBernadette Shaw-ngendima yabo ekujongeni kude abathathi-nxaxheba kwisifundo kwindawo yokulala Indima ebalulekileyo kwiYunivesithi. yase-Illinois.
Ingxelo ehambelanayo evela kwi-UMassMed News: Ngexesha lokutyelela kweNkomfa kwi-NIH campus, inyathelo le-RADx lagxininiswa.Isikolo sezoNyango iMass sinceda ukukhokela i-NIH RADx ukukhawulezisa itekhnoloji entsha yovavanyo lwe-COVID.Iindaba eziphambili: Isikolo seMass Medical sifumana i-100 yezigidi zeerandi yesibonelelo se-NIH ukukhuthaza uvavanyo olukhawulezayo, olufikelelekayo lwe-COVID-19
Questions or comments? Email: UMMSCommunications@umassmed.edu Tel: 508-856-2000 • 508-856-3797 (fax)
Ixesha lokuposa: Jul-14-2021